Lawrence Welch, Nuclera, confirmed to speak at DDW Symposium
The DDW Turning Science into Business Symposium will take place at the Francis Crick Institute in London on Tuesday 4 November.

DDW is delighted to welcome Lawrence Welch, Inside Sales Specialist, Nuclera, to the expert speaker line-up.
Lawrence Welch supports the adoption of eProtein Discovery for rapid protein production at Nuclera. With a PhD from the MRC-LMB and experience at GSK and Lightcast Discovery, he bridges science and strategy to accelerate access to challenging drug targets like membrane and undruggable proteins.
Welch will present on Unlocking drug targets: 48-Hour production of membrane proteins, E3 ligases, and transcription factors with eprotein discovery.
He will be joined by speakers from Cancer Research UK, the University of Cambridge, Alzheimer’s Research UK Oxford Drug Discovery Institute, Apollo Therapeutics, Gain Therapeutics and Shift Bioscience.
This free half day event will feature:
- 6 in-depth presentations from industry experts
- a panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite the drug discovery process
- an opportunity for networking
Sponsors:
- Nuclera (lead sponsor)
- Collaborative Drug Discovery (coffee break sponsor)
- Thermo Fisher Scientific (sponsor)
Registration is now open and is subject to availability and eligibility.
